Moderna to cut R&D expenses by $1.1B | Pharma Manufacturing

Sep 12, 2024  · This week, Moderna outlined its R&D progress and cost-cutting strategy, aiming for 10 product approvals by 2027 while reducing expenses. To streamline operations, …


Install CouponFollow Chrome Extension   CouponFollow Extension

$1
OFF

Moderna To Cut R&D Expenses By $1.1B | Pharma Manufacturing

2 weeks from now

Sep 12, 2024  · This week, Moderna outlined its R&D progress and cost-cutting strategy, aiming for 10 product approvals by 2027 while reducing expenses. To streamline operations, …

pharmamanufacturing.com

$1
OFF

Moderna Targets $1.1B In R&D Spending Cuts, Drops 5 Programs …

2 weeks from now

Sep 12, 2024  · Cutting the budget will take time, with Moderna forecasting R&D spending of $4.2 billion to $4.5 billion in 2025. The biotech disclosed a raft of pipeline changes as part of the …

fiercebiotech.com

$1
OFF

Moderna Shares Plunge On Plans To Cut $1.1 Billion In Costs, Launch …

2 weeks from now

Sep 12, 2024  · Moderna is deprioritizing certain parts of its pipeline, which involves pausing work on some products and scrapping others.

cnbc.com

20%
OFF

Moderna To Cut Costs, Trim Pipeline In R&D Revamp

2 weeks from now

Sep 12, 2024  · Dive Brief: Moderna will cut R&D spending by 20% and trim its pipeline as part of a strategic overhaul that will shift its research focus and put more resources into products that …

biopharmadive.com

$1
OFF

Moderna Will Cut $1.1bn Off Its Annual R&D Spend

2 weeks from now

Jan 27, 2025  · Moderna is showcasing its R&D pipeline to investors today, but the headline news is a decision to cut its R&D spend by a massive $1.1 billion a year from 2027, reversing years …

pharmaphorum.com

$1
OFF

Moderna Cuts Five Programmes To Save $1.1bn In R&D Costs

2 weeks from now

Sep 12, 2024  · Moderna will cut five clinical programmes amid plans to reduce $1.1bn of R&D costs following years of declining revenues.. The company highlighted its rejig in priorities at …

pharmaceutical-technology.com

23%
OFF

Moderna To Cut R&D Spending $1.1 B - STAT

2 weeks from now

Sep 12, 2024  · Moderna said Thursday it would cut its annual spending on research and development by 23%, or $1.1 billion, between 2024 and 2027 in a concession to investors who …

statnews.com

$1
OFF

Moderna Slashes Annual R&D Budget By $1.1B, Eyes 10

2 weeks from now

Sep 12, 2024  · Ahead of its annual R&D event on Thursday, Moderna laid out financial and development plans as part of a strategic reprioritization, as the company seeks to navigate the …

biospace.com

$1
OFF

Moderna Stock Drops On Plans To Cut $1.1B In R&D Costs - MSN

2 weeks from now

Moderna projects fiscal 2025 revenue of between $2.5 billion to $3.5 billion compared to analyst projections of $2.9 billion, and said Thursday that it expects to break even on an operating …

msn.com

$4
OFF

Moderna Cuts R&D Spending, Focuses On Oncology – Contract …

2 weeks from now

Sep 13, 2024  · Updated R&D Expenses The company is updating its projected 2024 research and development expenses to approximately $4.8 billion. It is also reducing its expected …

contractpharma.com

$1
OFF

Moderna To Slash Costs By $1.1B - LinkedIn

2 weeks from now

Sep 12, 2024  · Moderna, the biotech company known for developing one of the COVID-19 vaccines, plans to cut $1.1 billion in expenses by 2027 as it adjusts its business in the post …

linkedin.com

$1
OFF

Moderna Expects Lower Annual Sales, Expands Cost-Cutting …

2 weeks from now

Jan 13, 2025  · Moderna targets ten product approvals by 2027 while cutting R&D costs by $1.1 billion. FY2024 revenue reached $3 billion-$3.1 billion, with $9.5B in cash reserves.

benzinga.com

$1
OFF

Moderna Posts Surprise Profit As Covid Vaccine Sales Impress, Cost …

2 weeks from now

Nov 7, 2024  · Shares of Moderna were flat Thursday. Moderna is slashing expenses, with a recently announced goal of achieving $1.1 billion in savings by 2027, as it tries to recover from …

nbcnewyork.com

$1
OFF

Moderna Eyes MRNA Manufacturing Efficiencies As 3 Plants Set To …

2 weeks from now

Jan 7, 2025  · COVID-19 vaccine maker Moderna eyes mRNA manufacturing efficiencies as 3 plants set to come online in 2025 ... annual R&D expenses will be $1.1 billion less than in …

bioprocessintl.com

$1
OFF

JPM25: Moderna Slashes Guidance, Plots $1B In Cost Cuts This Year …

2 weeks from now

Jan 13, 2025  · The company has reduced its revenue guidance for 2025, as well, forecasting sales to land between $1.5 billion and $2.5 billion this year. The big biotech previously hoped …

fiercepharma.com

$3
OFF

Moderna Provides Business And Pipeline Updates At 43rd Annual …

2 weeks from now

Jan 13, 2025  · Achieved 2024 product sales of $3.0 to 3.1 billion (unaudited) and an ending cash balance of approximately $9.5 billion (unaudited) Updates 2025 expected revenue range to …

modernatx.com

$1
OFF

Moderna Plans $1.1B In R&D And Program Cuts, Delays Break-even …

2 weeks from now

Sep 12, 2024  · Stéphane Bancel has relented to Wall Street’s desire for cost-cutting and reining in Moderna’s pipeline. To kick off its annual R&D day in New York, Moderna said Thursday that it ...

endpts.com

FAQs about Moderna to cut R&D expenses by $1.1B | Pharma Manufacturing Coupon?

Will Moderna cut costs by $1.1 billion by 2027?

Moderna said it expects the moves to lower expenses by $1.1 billion by 2027. Moderna (MRNA) shares tumbled in pre-market trading Thursday as the company said it plans to cut costs and suspend or end development of some products as it focuses on later-stage trials. ...

Will Moderna cut its research & development spending by 23%?

By Matthew Herper and Jason Mast Moderna said Thursday it would cut its annual spending on research and development by 23%, or $1.1 billion, between 2024 and 2027 in a concession to investors who have viewed the company’s outlays following its pandemic-era windfall as profligate. ...

How much will Moderna spend on R&D in 2027?

In September, Moderna unveiled key updates at its annual R&D Day by reducing annual R&D spending by $1.1 billion by 2027, enabling a focus on ten prioritized products. The company expects R&D expenses to fall from $4.8 billion in 2024E to $3.6 billion—$3.8 billion in 2027. ...

What will Moderna do to reduce costs by 2027?

The company said it will focus on getting FDA approval for 10 products to treat RSV and cancer, along with a combination COVID and flu vaccine. Moderna said it expects the moves to lower expenses by $1.1 billion by 2027. ...

Will Moderna get FDA approval for 10 new products?

Moderna said Thursday that based on current trial data, it expects to receive Food and Drug Administration (FDA) approval for 10 new products over the next three years while trimming its research and development (R&D) spending by about $1.1 billion by 2027. ...

How much money did Moderna make in FY2024?

Moderna targets ten product approvals by 2027 while cutting R&D costs by $1.1 billion. FY2024 revenue reached $3 billion-$3.1 billion, with $9.5B in cash reserves. ...

Install CouponFollow Extension on Chrome

Install the CouponFollow extension to search for discount codes when shopping the fastest!

Install CouponFollow Chrome Extension   Install CouponFollow Chrome Extension